From: Nanovaccines to combat drug resistance: the next-generation immunisation
Disease | Nanocarrier/Nanovaccine | References |
---|---|---|
Bacterial infection | ||
Tuberculosis | Chitosan nanoparticle | [48] |
Anthrax | Poly(D, L-lactic-co-glycolic acid) nanospheres | [49] |
GAS infection | Lipopeptide-based | [50] |
Tetanus | Gold nanoparticles | [51] |
Chlamydia | Vault | [52] |
Viral infection | ||
Influenza | Liposomes, gold nanoparticles | |
HIV | Gold nanoparticles, chitosan, and hyaluronic acid | |
Hepatitis B | Poly(D, L-lactic-co-glycolic acid) nanospheres | [57] |
Dengue | Liposomes | [58] |
Foot and mouth disease | Gold nanoparticles | [59] |
Newcastle disease | Chitosan nanoparticles | [60] |
Parasitic infection | ||
Toxoplasmosis | α-helix self-assembling peptide nanoparticles | [61] |
Malaria | Iron oxide nanoparticles | [62] |